ArticleFrontiers in oncology2021

A Robust Metabolic Enzyme-Based Prognostic Signature for Head and Neck Squamous Cell Carcinoma.

Zizhao Mai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.